Literature DB >> 20440075

IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection.

Galit Alter1, Daniel Kavanagh, Suzannah Rihn, Rutger Luteijn, David Brooks, Michael Oldstone, Jan van Lunzen, Marcus Altfeld.   

Abstract

Persistent levels of IL-10 play a central role in progressive immune dysfunction associated with chronic viral infections such as HIV, but the underlying mechanisms are poorly understood. Because IL-10 affects the phenotypic and functional properties of DCs, which are responsible for initiating adaptive immune responses, we investigated whether IL-10 induces changes in DC phenotype and function in the context of HIV infection. Here, we show that IL-10 treatment of immature and mature human DCs in culture induced contrasting phenotypic changes in these populations: immature DCs exhibited aberrant resistance to NK cell-mediated elimination, whereas mature DCs exhibited increased susceptibility to NKG2D-dependent NK elimination. Treatment of immature and mature DCs with HIV resulted in potent IL-10 secretion and the same phenotypic and functional changes observed in the IL-10-treated cells. Consistent with these in vitro data, LNs isolated from individuals infected with HIV exhibited aberrant accumulation of a partially "immature" DC population. Together, these data suggest that the progressive immune dysfunction observed in chronic viral infections might be caused in part by IL-10-induced reversal of DC susceptibility to NK cell-mediated elimination, resulting in the accumulation of poorly immunogenic DCs in LNs, the sites of adaptive immune response induction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20440075      PMCID: PMC2877944          DOI: 10.1172/JCI40913

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Upregulation of PD-L1 on monocytes and dendritic cells by HIV-1 derived TLR ligands.

Authors:  Angela Meier; Aranya Bagchi; Harlyn K Sidhu; Galit Alter; Todd J Suscovich; Daniel G Kavanagh; Hendrik Streeck; Mark A Brockman; Sylvie LeGall; Judith Hellman; Marcus Altfeld
Journal:  AIDS       Date:  2008-03-12       Impact factor: 4.177

Review 2.  Tolerogenic dendritic cells for autoimmune disease and transplantation.

Authors:  A W Thomson; P D Robbins
Journal:  Ann Rheum Dis       Date:  2008-12       Impact factor: 19.103

Review 3.  Pathogenesis of HIV: non-specific immune hyperactivity and its implications for vaccines.

Authors:  Martin Cadogan; Angus G Dalgleish
Journal:  Clin Med (Lond)       Date:  2008-06       Impact factor: 2.659

Review 4.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

5.  Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections.

Authors:  Andrea R Stacey; Philip J Norris; Li Qin; Elizabeth A Haygreen; Elizabeth Taylor; John Heitman; Mila Lebedeva; Allan DeCamp; Dongfeng Li; Douglas Grove; Steven G Self; Persephone Borrow
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

Review 6.  Immune activation and inflammation in HIV-1 infection: causes and consequences.

Authors:  V Appay; D Sauce
Journal:  J Pathol       Date:  2008-01       Impact factor: 7.996

7.  Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.

Authors:  Vincent Lombardi; Laurence Van Overtvelt; Stéphane Horiot; Philippe Moingeon
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

Review 8.  T-cell exhaustion in HIV infection.

Authors:  Mohamed El-Far; Rabih Halwani; Elias Said; Lydie Trautmann; Mehrnoosh Doroudchi; Loury Janbazian; Simone Fonseca; Julien van Grevenynghe; Bader Yassine-Diab; Rafick-Pierre Sékaly; Elias K Haddad
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

Review 9.  Immune responses against persistent viral infections: possible avenues for immunotherapeutic interventions.

Authors:  Shinichiro Fuse; Michael J Molloy; Edward J Usherwood
Journal:  Crit Rev Immunol       Date:  2008       Impact factor: 2.214

10.  IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection.

Authors:  David G Brooks; Andrew M Lee; Heidi Elsaesser; Dorian B McGavern; Michael B A Oldstone
Journal:  J Exp Med       Date:  2008-03-10       Impact factor: 14.307

View more
  48 in total

Review 1.  Boosting vaccine efficacy the natural (killer) way.

Authors:  Carolyn E Rydyznski; Stephen N Waggoner
Journal:  Trends Immunol       Date:  2015-08-10       Impact factor: 16.687

Review 2.  DCs and NK cells: critical effectors in the immune response to HIV-1.

Authors:  Marcus Altfeld; Lena Fadda; Davor Frleta; Nina Bhardwaj
Journal:  Nat Rev Immunol       Date:  2011-03       Impact factor: 53.106

Review 3.  Innate immunity against HIV-1 infection.

Authors:  Marcus Altfeld; Michael Gale
Journal:  Nat Immunol       Date:  2015-06       Impact factor: 25.606

Review 4.  Innate immunity in acute HIV-1 infection.

Authors:  Persephone Borrow
Journal:  Curr Opin HIV AIDS       Date:  2011-09       Impact factor: 4.283

Review 5.  Evasion from NK cell-mediated immune responses by HIV-1.

Authors:  Stephanie Jost; Marcus Altfeld
Journal:  Microbes Infect       Date:  2012-05-21       Impact factor: 2.700

Review 6.  NK cells and their ability to modulate T cells during virus infections.

Authors:  Kevin D Cook; Stephen N Waggoner; Jason K Whitmire
Journal:  Crit Rev Immunol       Date:  2014       Impact factor: 2.214

Review 7.  The role of dendritic cells in driving genital tract inflammation and HIV transmission risk: are there opportunities to intervene?

Authors:  Muki S Shey; Nigel J Garrett; Lyle R McKinnon; Jo-Ann S Passmore
Journal:  Innate Immun       Date:  2013-11-26       Impact factor: 2.680

Review 8.  Dendritic cell dysregulation during HIV-1 infection.

Authors:  Elizabeth Miller; Nina Bhardwaj
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 9.  Immunogenetics of HIV disease.

Authors:  Maureen P Martin; Mary Carrington
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

10.  Impairment in natural killer cells editing of immature dendritic cells by infection with a virulent Trypanosoma cruzi population.

Authors:  Estela I Batalla; Agustina M Pino Martínez; Carolina V Poncini; Tomás Duffy; Alejandro G Schijman; Stella M González Cappa; Catalina D Alba Soto
Journal:  J Innate Immun       Date:  2013-05-08       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.